Applied Therapeutics, Inc (APLT)

Etorro trading 970x250
Applied Therapeutics, Inc (APLT) Logo

About Applied Therapeutics, Inc

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase I/II for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York. Address: 545 Fifth Avenue, New York, NY, United States, 10017

Applied Therapeutics, Inc News and around…

Latest news about Applied Therapeutics, Inc (APLT) common stock and company :

Applied Therapeutics Reports Additional Pediatric Biomarker Data from ACTION-Galactosemia Kids
18 Oct, 2021 Yahoo! Finance

Substantial and statistically significant reduction in plasma galactitol of 40% with new weight-based dosing parameters Baseline galactitol levels clearly correlated with baseline clinical functional outcomes NEW YORK, Oct. 18, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported additional biomarker

Applied Therapeutics Inc. (APLT) Upgraded to Buy: Here's Why
06 Oct, 2021 Yahoo! Finance

Applied Therapeutics Inc. (APLT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

12 Health Care Stocks Moving In Monday's Intraday Session
27 Sep, 2021 FinancialContent

Gainers Keros Therapeutics (NASDAQ:KROS) stock moved upwards by 26.51% to $41.75 during Monday's regular session. ...

The Implied Analyst 12-Month Target For IBBQ
23 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Nasdaq Biotechnology ETF (IBBQ), we found that the implied analyst target price for the ETF based upon its underlying holdings is $33.51 per unit.

Notable Tuesday Option Activity: APLT, SIX, DISCA
21 Sep, 2021 FinancialContent

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Applied Therapeutics Inc (APLT), where a total volume of 556 contracts has been traded thus far today, a contract volume which is representative of approximately 55,600 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 51.9% of APLT's average daily trading volume over the past month, of 107,215 shares..

The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
21 Sep, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Is Applied Therapeutics (NASDAQ:APLT) Using Debt Sensibly?
17 Sep, 2021 Yahoo! Finance

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Applied Therapeutics Stock Drops On Delayed NDA Submission For Its Lead Candidate
09 Sep, 2021 FinancialContent

Applied Therapeutics Inc(NASDAQ: APLT) hasreported initial biomarker datafrom the pediatric ACTION-Galactosemia ...

12 Health Care Stocks Moving In Thursday's Pre-Market Session
09 Sep, 2021 FinancialContent

Gainers Soligenix (NASDAQ:SNGX) stock increased by 22.85% to $1.29 during Thursday's pre-market session. The ...

Applied Therapeutics Reports Initial Pediatric Biomarker Data from ACTION-Galactosemia Kids
09 Sep, 2021 FinancialContent
Applied Therapeutics Reports Initial Pediatric Biomarker Data from ACTION-Galactosemia Kids
09 Sep, 2021 Yahoo! Finance

Substantial and statistically significant reduction in plasma galactitol Baseline analysis demonstrates clear relationship between plasma galactitol level and severity of disease in pediatric Galactosemia patients NEW YORK, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Applied Therapeutics, Inc. (Nasdaq: APLT), a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need, today reported initial biomar

60 Biggest Movers From Friday
30 Aug, 2021 FinancialContent

Gainers Vinco Ventures, Inc. (NASDAQ: BBIG) shares rose 80.9% to close at $5.30 on Friday. The company recently reported a Q2 loss ...

Mid-Afternoon Market Update: Crude Oil Rises 2%; Navios Maritime Acquisition Shares Climb On Merger News
27 Aug, 2021 FinancialContent

Toward the end of trading Friday, the Dow traded up 0.63% to 35,436.38 while the NASDAQ rose 1.23% to 15,130.14. The S&P also rose, ...

Mid-Day Market Update: Dow Jumps Over 200 Points; Bill.com Shares Spike Higher
27 Aug, 2021 FinancialContent

Midway through trading Friday, the Dow traded up 0.69% to 35,457.78 while the NASDAQ rose 1.03% to 15,099.70. The S&P also rose, ...

35 Stocks Moving In Friday's Mid-Day Session
27 Aug, 2021 FinancialContent

Gainers Support.com, Inc. (NASDAQ: SPRT) shares climbed 87% to $36.83 on abnormally high volume amid continued volatility. The ...

Mid-Morning Market Update: Markets Open Higher; Big Lots Reports Downbeat Profit
27 Aug, 2021 FinancialContent

Following the market opening Friday, the Dow traded up 0.30% to 35,320.11 while the NASDAQ rose 0.27% to 14,986.36. The S&P also ...

BIB's Holdings Imply 20% Gain Potential
23 Aug, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $118.06 per unit.

Applied Therapeutics Reports Second Quarter 2021 Financial Results
12 Aug, 2021 FinancialContent
Implied IBBQ Analyst Target Price: $31
23 Jul, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco Nasdaq Biotechnology ETF (IBBQ), we found that the implied analyst target price for the ETF based upon its underlying holdings is $31.16 per unit.

APLT Makes Notable Cross Below Critical Moving Average
01 Jul, 2021 FinancialContent

In trading on Thursday, shares of Applied Therapeutics Inc (APLT) crossed below their 200 day moving average of $20.51, changing hands as low as $20.26 per share. Applied Therapeutics Inc shares are currently trading down about 2.5% on the day..

60 Biggest Movers From Yesterday
29 Jun, 2021 FinancialContent

Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has ...

12 Health Care Stocks Moving In Monday's After-Market Session
28 Jun, 2021 FinancialContent

Gainers SCWorx (NASDAQ:WORX) shares rose 8.38% to $1.81 during Monday's after-market session. SCWorx's trading volume hit 504.7K ...

Applied Therapeutics Added to Russell Microcap® Index
28 Jun, 2021 FinancialContent
Applied Therapeutics Announces Presentation of Data on the Prevalence of Diabetic Cardiomyopathy at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association
25 Jun, 2021 FinancialContent
Add Up The Pieces: BIB Could Be Worth $112
22 Jun, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares ProShares Ultra Nasdaq Biotechnology ETF (BIB), we found that the implied analyst target price for the ETF based upon its underlying holdings is $111.99 per unit.

Applied Therapeutics to Present on Diabetic Cardiomyopathy and Prevalence of Disease at the 81st Scientific Sessions of the 2021 Annual Meeting of the American Diabetes Association
21 Jun, 2021 FinancialContent
Applied Therapeutics Gets Fast Track Designation from FDA
17 Jun, 2021 Yahoo! Finance

Applied Therapeutics says drug candidate to treat rare disorder affecting sugar processing gets fast track designation from the FDA.

The Daily Biotech Pulse: Biogen Faces Another Clinical Setback, CureVac's COVID-19 Vaccine Study Fails, Moment Of Reckoning For Orphazyme
17 Jun, 2021 FinancialContent

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...

Applied Therapeutics Stock Moves Higher On FDA Fast Track Review For AT-007 In Rare Metabolic Disorder
17 Jun, 2021 FinancialContent

TheFDA has granted Fast Track designationtoApplied Therapeutics Inc's(NASDAQ: APLT) AT-007 to treat ...

Applied Therapeutics Granted Fast Track Designation by FDA for AT-007 for Galactosemia
17 Jun, 2021 FinancialContent

Applied Therapeutics, Inc (APLT) is a NASDAQ Common Stock listed in , ,

970x250